powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1013321041
Paul Joudrey
M.D.
Addiction Medicine
New Haven,
CT
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (1)
CCN 390164
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
13
Unique beneficiaries
—
Total services
15
Distinct HCPCS
1
Medicare payment
$752
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 9 Addiction Medicine providers in CT — bottom quintile (cohort median 48).
PRESCRIBING · PART D · 2024
Total Rx claims
305
Beneficiaries
—
Total drug cost
$40K
Distinct drugs
12
Brand share
39.0%
Top prescribed drugs
Buprenorphine Hcl/Naloxone Hcl
70 claims
Atorvastatin Calcium
59 claims
Amlodipine Besylate
35 claims
Gabapentin
25 claims
Semaglutide
18 claims
QUALITY · MIPS · 2024
Final MIPS score
80.9
Quality
61.9
Cost
74.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.25%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
